As Ireland signed up today [Friday] to the BeNeLuxA Initiative on pricing and supply of innovative medicines, the Irish Pharmaceutical Healthcare Association (IPHA) has said the focus of policymakers and industry must remain on fixing a slow and inefficient medicines approvals process for Irish patients
The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry in Ireland, has said a continued focus on innovation is key to unlocking the potential of new medicines to improve healthcare outcomes and attract investments in the future.
NEW IPHA RESEARCH SHOWS THAT IRELAND CONTINUES TO LAG EUROPE
The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47 research based pharmaceutical companies in Ireland has welcomed the publication of a report on Evaluating Orphan Drugs which has been published by the Joint Oireachtas Committee on Health.
Revised ‘drug iceberg’ report a valuable contribution to ongoing debate on how best to ensure patients have timely access to the best medicines
Dublin, 21 February 2018 – The biopharmachem sector maintained its position as the largest exporter of goods from Ireland in 2017 with record total exports of €67.8 billion, up 2% on the previous year*. The sector now accounts for 55% of overall Irish exports of goods (excluding services), the BioPharma Ambition Conference 2018 was told today.